ReviewCureus2024
The Psychology Behind the Efficacy of a Buddy System for Enhancing Retention in Dermatological Clinical Trials.
Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- The power of patient engagement at Peace and Love Hospitals in Ghana.Nature medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retention in dermatological clinical trials is critical for ensuring the validity and reliability of study outcomes, yet participant dropout remains a pervasive challenge. In this analysis, the primary aim is to explore the psychological mechanisms underpinning the efficacy of a buddy system in enhancing retention rates in such trials. The buddy system, where participants are paired with peers who have previously participated in similar clinical trials offers mutual support and leverages the principles of social bonding, accountability, and shared experience to foster commitment and reduce attrition. The novelty of this approach lies in its focus on the psychological and emotional dimensions of trial participation, rather than solely on logistical or incentive-based strategies. Implementing a buddy system draws on theories of social support and motivation, suggesting that the presence of a buddy can alleviate anxiety, increase perceived value, and enhance the overall clinical trial experience. Future research should investigate the long-term effects of buddy systems across diverse demographic groups and dermatological conditions, as well as potential adaptations for virtual trial settings. In conclusion, integrating a buddy system into dermatological clinical trials represents an innovative strategy that could significantly improve retention, thereby strengthening the robustness of clinical data and advancing dermatological research.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.